Mycosynthetix owns a unique collection of fungi that are the source of a rich variety of fungal metabolites for lead discovery for medicine and agriculture.

Mycosynthetix in Brazil for Thinking Big About Small Beings: Recent Advances On Microbial Diversity, Ecology and Biodiscovery

Mycosynthetix presented at Thinking Big About Small Beings: Recent Advances On Microbial Diversity, Ecology and Biodiscovery in São Paulo, Brazil on April 28-29. The presentation was titled Searching for Anti-Cancer and Anti-Parasite Leads from Filamentous Fungi. Abstract: Fungi have been the source of numerous successful medicines and pesticides although it isn’t obvious why fungi make […]

Read full story
Prof Toru Okuda, President of the Mycological Society of Japan, and Dr. Pearce at the kabuki theatre in the Ginza

Recent Natural Products Presentations by Mycosynthetix

Mycosynthetix CEO Dr. Cedric Pearce has given presentations on natural products in Japan and Canada recently. In Japan he spoke at the Mycological Society of Japan Meeting at the Tokyo University of Agriculture and the Microbial Workshop at Tamagawa University. In Canada he presented at the Weed Science Society of America/Canadian Weed Science Society Joint […]

Read full story

Mycosynthetix Discusses Fungi on Radio In Vivo

Mycosynthetix CEO Dr. Cedric Pearce was featured on the May 8, 2013 edition of Radio In Vivo, a weekly broadcast that features in-depth interviews with the researchers who make the Research Triangle of North Carolina one of the world’s leading hubs of scientific research and development.  In the interview, Dr. Pearce discusses the origins of Mycosythetix, […]

Read full story

New Website Launched

Mycosynthetix is pleased to present our new website.  If you encounter any problems using our website, please don’t hesitate to let us know.

Read full story

Mycosynthetix Celebrates 10 Years

We are pleased to celebrate 10 years of Mycosynthetix.  We look forward to further developing the potential for world-changing natural products from the fungal kingdom in the coming decade.

Read full story

Mycosynthetix Awarded 2 Therapeutic Discovery Project Grants

Mycosynthetix, Inc has been awarded two Therapeutic Discovery Project Grants by the IRS. The grants are for projects that “showed significant potential to produce new and cost-saving therapies, support jobs and increase U.S. competitiveness.”

Read full story

Antimalarial Constituents of Microorganisms

Mycosynthetix CEO, Dr. Cedric Pearce, and colleagues presented at the 51st Annual Meeting of the American Society of Pharmacognosy in Tampa, Florida this July. Their presentation focused on the antimalarial compounds which have been discovered within microorganisms, such as the fungi in the Mycosynthetix library.

Read full story

Green Ethanol from Biomass? Verenium Looks to Mycosynthetix Fungi

“Fungi are the most prolific degraders of plant biomass in nature and are expected to hold the keys to unlocking the potential of cellulose as a renewable feedstock.” Shortly after the posting of this release, Verenium’s biofuels division was acquired by British Petroleum. Mycosynthetix’ contract has been transferred to BP in the exchange.

Read full story

Mycosynthetix Awarded an SBIR Grant to Work on New Tuberculosis Antibiotics

Mycosynthetix, Inc. was recently awarded a Phase I Small Business Innovation Research grant from the National Institutes of Allergy and Infectious Diseases for the project New Tuberculosis Antibiotics from Filamentous Fungi.

Read full story

Mevalocidin – novel natural herbicide under development

Mycosynthetix is currently developing Mevalocidin, a new herbicidal natural product from fungal fermentation, for use in organic farming. The US Patent for Mevalocidin (PDF) was issued on July 1st, 2008. Dow AgroSciences LLC of Indianapolis and Mycosynthetix Inc have entered into a royalty-bearing agreement for Mycosynthetix to develop and market this herbicide. Contact Dr. Cedric […]

Read full story